» Articles » PMID: 39841856

Beyond , Pharmaceutical Molecule Production in Cell-Free Systems and the Use of Noncanonical Amino Acids Therein

Overview
Journal Chem Rev
Date 2025 Jan 22
PMID 39841856
Authors
Affiliations
Soon will be listed here.
Abstract

Throughout history, we have looked to nature to discover and copy pharmaceutical solutions to prevent and heal diseases. Due to the advances in metabolic engineering and the production of pharmaceutical proteins in different host cells, we have moved from mimicking nature to the delicate engineering of cells and proteins. We can now produce novel drug molecules, which are fusions of small chemical drugs and proteins. Currently we are at the brink of yet another step to venture beyond nature's border with the use of unnatural amino acids and manufacturing without the use of living cells using cell-free systems. In this review, we summarize the progress and limitations of the last decades in the development of pharmaceutical protein development, production in cells, and cell-free systems. We also discuss possible future directions of the field.

References
1.
Iwane Y, Hitomi A, Murakami H, Katoh T, Goto Y, Suga H . Expanding the amino acid repertoire of ribosomal polypeptide synthesis via the artificial division of codon boxes. Nat Chem. 2016; 8(4):317-25. DOI: 10.1038/nchem.2446. View

2.
Tai Y, Mayes P, Acharya C, Zhong M, Cea M, Cagnetta A . Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma. Blood. 2014; 123(20):3128-38. PMC: 4023420. DOI: 10.1182/blood-2013-10-535088. View

3.
Martin R, Des Soye B, Kwon Y, Kay J, Davis R, Thomas P . Cell-free protein synthesis from genomically recoded bacteria enables multisite incorporation of noncanonical amino acids. Nat Commun. 2018; 9(1):1203. PMC: 5865108. DOI: 10.1038/s41467-018-03469-5. View

4.
Beattie A, Dunkelmann D, Chin J . Quintuply orthogonal pyrrolysyl-tRNA synthetase/tRNA pairs. Nat Chem. 2023; 15(7):948-959. PMC: 7615293. DOI: 10.1038/s41557-023-01232-y. View

5.
Stech M, Hust M, Schulze C, Dubel S, Kubick S . Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments. Eng Life Sci. 2015; 14(4):387-398. PMC: 4374706. DOI: 10.1002/elsc.201400036. View